WPI 2281 (Zolpidem Tartrate Extended-Release 6.25 mg)
Pill with imprint WPI 2281 is Green, Round and has been identified as Zolpidem Tartrate Extended-Release 6.25 mg. It is supplied by Watson Laboratories, Inc..
Zolpidem is used in the treatment of insomnia and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. Risk cannot be ruled out during pregnancy. Zolpidem 6.25 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for WPI 2281
Zolpidem Tartrate Extended-Release
- Imprint
- WPI 2281
- Strength
- 6.25 mg
- Color
- Green
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Miscellaneous anxiolytics, sedatives and hypnotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Watson Laboratories, Inc.
- National Drug Code (NDC)
- 00591-2281
More about zolpidem
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 938 Reviews
- Drug class: miscellaneous anxiolytics, sedatives and hypnotics
- FDA Alerts (4)
Consumer resources
- Patient Information
- Zolpidem (Advanced Reading)
- Zolpidem Oral, Oromucosal (Advanced Reading)
- Zolpidem Extended-Release Tablets
- Zolpidem Sublingual Tablets (Edluar)
- ... +3 more
- Other brands
- Ambien, Ambien CR, Zolpimist, Intermezzo, Edluar
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.